220100.KQ Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
All Sources
YouTube
Twitter
Reddit
Substack
Insider
Loading...
0 selected
All directions
▲ Long
▼ Short
◦ Others
Any score
LOW+
MED+
HIGH
03:00
May 04
Prostate cancer approval catalyst
Futurechem received domestic approval for its prostate cancer treatment after a long delay. The stock has bottomed and is expected to improve from here.
MED

About 220100.KQ Analyst Coverage

Buzzberg tracks 220100.KQ across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.